English name | Alfatinib Maleate 马来酸阿法替尼 |
Synonyms | BIBW2992DiMaleate;BIBW2992-MA2;Afatinib(diMaleate);Afatinib(diMaleate),BIBW2992;2-ButenaMide,N-[4-[(3-chloro-4-fluorophenyl)aMino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-Chemicalbook6-quinazolinyl]-4-(diMethylaMino)-,(2E)-,(2Z)-2-butenedioate(1:2);(2E)-N-(4-[(3-chloro-4-fluorophenyl)aMino]-7-{[(3S);AfatinibdoubleMaleate;Afatinib(BIBW2992)Dimaleate |
CAS | 850140-73-7 |
EINECS | 810-416-1 |
Molecular formula | C28H29ClFN5O7 |
Molecular weight | 602.02 |
Chemical formula |
|
Melting point | >237oC (dec.) |
Solubility | DMSO (Slightly), Methanol (Slightly) |
Storage condition | Refrigerator |
Appearance | Solid |
Colour | White to Pale Yellow |
InChIKey | LIENDGDDWJRJLO-LBXKZPGENA-N |
SMILES | C(/C(=O)O)=C/C(=O)O.N(C1C=CC(F)=C(Cl)C=1)C1=NC=NC2C=C(O[C@@H]3COCC3)C(NC(=O)/C=C/CN(C)C)=CC1=2 |&1:25,r| |
HS | 29339900 |
Use | Afatinib bismaleate is an organic synthesis intermediate and pharmaceutical intermediate, which can be used in laboratory research and development process and chemical and pharmaceutical synthesis process |
Package | （According to user requirements） |
